ISBN: 9783642742743 - the perception and management of drug safety risks (health systems research) (13 resultados)

ISBN: 
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (13)

a

Intervalo de precios personalizado (EUR)

a

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda

    Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Usado - Como Nuevo

    EUR 126,85

    Envío por EUR 2,35 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 15 disponibles

    Condición: As New. Unread book in perfect condition.

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda

    Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 135,07

    Envío por EUR 2,35 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 15 disponibles

    Condición: New.

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda

    Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 130,45

    Envío por EUR 13,40 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New. In English.

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 124,85

    Envío por EUR 35,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.…

  • Idioma: Inglés

    Editorial: Springer, 2012

    3642742742 / 9783642742743

    • Tapa blanda

    Librería: Revaluation Books, Exeter, Reino UnidoRevaluation Books

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 157,36

    Envío por EUR 11,87 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Paperback. Condición: Brand New. reprint edition. 240 pages. 9.40x6.80x0.60 inches. In Stock.

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda

    Librería: Books Puddle, Woodside, NY, Estados Unidos de AmericaBooks Puddle

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 166,05

    Envío por EUR 3,56 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 4 disponibles

    Condición: New. pp. xxiii + 210.

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda

    Librería: Buchpark, Trebbin, AlemaniaBuchpark

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Usado - Excelente

    EUR 91,33

    Envío por EUR 105,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Condición: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat­ ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.…

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 86,24

    Envío por EUR 5,50 
    Se envía de Italia a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: new. Questo è un articolo print on demand.

  • Idioma: Inglés

    Editorial: Springer, Springer Dez 2011, 2011

    3642742742 / 9783642742743

    • Tapa blanda
    • Impresión bajo demanda

    Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 106,99

    Envío por EUR 23,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public. 240 pp. Englisch.…

  • Idioma: Inglés

    Editorial: Springer Berlin Heidelberg, 2011

    3642742742 / 9783642742743

    • Tapa blanda
    • Impresión bajo demanda

    Librería: moluna, Greven, Alemaniamoluna

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 92,27

    Envío por EUR 48,99 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product.…

  • Idioma: Inglés

    Editorial: Springer, Springer Dez 2011, 2011

    3642742742 / 9783642742743

    • Tapa blanda
    • Impresión bajo demanda

    Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 106,99

    Envío por EUR 60,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In the past two decades public debate about the risks, benefits, and safety associated with drugs has intensified. Public disputes over risks are brought to court when individuals seek compensation for health problems attributed to a pharmaceutical product. The issue reaches legislatures and regulatory agencies when consumer advocates seek to influence the standards of drug usage. Front-page news tends to focus on accidents or other risk events with drugs. Drug risk and drug safety have become an important political issue. Drug regulat ory agencies have been instituted, and their responsibility has increased. The approval to market a drug is dependent on a set of sophisticated studies executed according to strict protocols and scientifically defined criteria. Drug surveillance activities have gained recognition, and reporting systems to identify drug safety problems have been strengthened. The understanding and management of drug safety is, nonetheless, beset by doubts, disagreements, and disputes. Conflict occurs over the significance of risk, the adequacy of evidence, the methodologies used to evaluate and measure risk, the standards that guide regulation, and the optimal means of communicating risk information to the public.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 240 pp. Englisch.…

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Majestic Books, Hounslow, Reino UnidoMajestic Books

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 173,72

    Envío por EUR 7,71 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 4 disponibles

    Condición: New. Print on Demand pp. xxiii + 210 29 Figures.

  • Idioma: Inglés

    Editorial: Springer, 2011

    3642742742 / 9783642742743

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Biblios, frankfurt am main, HESSE, AlemaniaBiblios

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 174,46

    Envío por EUR 9,95 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 4 disponibles

    Condición: New. PRINT ON DEMAND pp. xxiii + 210.